healthprotocol.wiki

can-2409_0000_rct_can-2409-with-radiotherapy-for-localized-prostate-cancer-a-phase-3-randomized-placebo-controlled-clinical-trial

5 findings

Protocol
therapy-immunotherapy-can-two-four-zero-nine-viral-radiotherapy-combined
Outcome
oncology-pathological-complete-response-at-2-year-biopsy-achieved-binary-measured
n
497
effect
20
attribution
80
Protocol
therapy-immunotherapy-can-two-four-zero-nine-viral-radiotherapy-combined
Outcome
oncology-psa-nadir-less-than-0-point-2-ng-per-ml-achieved-binary-measured
n
497
effect
15
attribution
70
Protocol
therapy-immunotherapy-can-two-four-zero-nine-viral-radiotherapy-combined
Outcome
safety-serious-adverse-events-count-cohort-measured
n
497
effect
0
attribution
80
Protocol
therapy-immunotherapy-can-two-four-zero-nine-viral-radiotherapy-combined
Outcome
survival-disease-free-proportion-cohort-measured
n
497
effect
30
attribution
85
Protocol
therapy-immunotherapy-can-two-four-zero-nine-viral-radiotherapy-combined
Outcome
survival-prostate-cancer-specific-disease-free-proportion-cohort-measured
n
497
effect
30
attribution
80